Cargando…
A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
One of the novel PD-1 antibodies/immune checkpoint inhibitors, nivolumab is reported to be associated with a wide range of immune-related adverse events (irAEs). We hereby report a case of isolated adrenocorticotropic hormone (ACTH) deficiency developing in a patient with squamous cell lung cancer (...
Autores principales: | Sato, Yozo, Tanaka, Yosuke, Hino, Mitsunori, Seike, Masahiro, Gemma, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356048/ https://www.ncbi.nlm.nih.gov/pubmed/30740300 http://dx.doi.org/10.1016/j.rmcr.2019.01.021 |
Ejemplares similares
-
Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report
por: Takeno, Ayumu, et al.
Publicado: (2019) -
Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report
por: Simeni Njonnou, Sylvain Raoul, et al.
Publicado: (2022) -
Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer
por: Takaya, Kazuhiko, et al.
Publicado: (2017) -
Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel
por: Bomback, Andrew S, et al.
Publicado: (2011) -
A case of small-cell lung cancer with adrenocorticotropic hormone deficiency induced by nivolumab
por: Zhu, Yan, et al.
Publicado: (2019)